X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GMDA

Closed

Gamida Cell Ltd

0.017
-0.001 (-5.43%)
Last Update: 24 May 2024 16:30:00
Yesterday: 0.0184
Day's Range: 0.016 - 0.0182
Send
When Written:
 
0.8178
Gamida Cell Ltd is a clinical-stage biotechnology company that specializes in developing cell therapies for the treatment of cancer and rare genetic diseases. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

Gamida Cell's lead product candidate is called omidubicel, which is a stem cell therapy designed to improve the outcomes of bone marrow transplants for patients with blood cancers and other serious blood disorders. The company has also developed other cell therapies, including GDA-201, which is being developed for the treatment of solid tumors, and NAM-NK, which is being developed for the treatment of various types of cancer.

Gamida Cell has partnerships with several pharmaceutical companies, including Novartis and Lonza, to help develop and manufacture its cell therapies. The company has raised over $300 million in funding from investors, including venture capital firms and public market investors.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X